Evaxion soars on collaboration with Afrigen for gonorrhea vaccine

Evaxion A/S

20/09/2023 16:01

** Shares of Evaxion Biotech  EVAX.O  rise 39% to 67 cents
    ** Co says it is collaborating with Cape Town-based
privately held Afrigen Biologics to develop an mRNA vaccine for
sexually transmitted disease gonorrhea 
    ** Says the collaboration will make use of co's AI-driven
platform EDEN to identify vaccine candidates 
    ** Including session moves, shares down 64.5% YTD

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))